Effect of Intramyocardial Injection of Autologous Bone MarrowDerived Mononuclear Cells on Perfusion, Function, and Viability in Patients with Drug-Refractory Chronic Ischemia
Saskia L.M.A. Beeres, MD1,
Jeroen J. Bax, MD, PhD1,
Petra Dibbets2,
Marcel P.M. Stokkel, MD, PhD2,
Katja Zeppenfeld, MD, PhD1,
Willem E. Fibbe, MD, PhD3,
Ernst E. van der Wall, MD, PhD1,
Martin J. Schalij, MD, PhD1 and
Douwe E. Atsma, MD, PhD1
1 Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands; 2 Department of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands; and 3 Department of Hematology, Leiden, University Medical Center, Leiden, The Netherlands

View larger version (57K):
[in a new window]
|
FIGURE 1. SPECT images (vertical long axes) from representative patient. 99mTc-Tetrofosmin SPECT shows stress-induced ischemia at baseline in inferior wall (arrow). At 3-mo follow-up, ischemia in inferior wall has resolved. Metabolic imaging shows normal 18F-FDG uptake at baseline and 3-mo follow-up in that region, indicating no scar formation after intramyocardial injection of bone marrowderived mononuclear cells.
|
|

View larger version (15K):
[in a new window]
|
FIGURE 2. Patients' segmental stress and rest scores improved significantly 3 mo after autologous bone marrowderived mononuclear cell injection. Magnitude of increase in stress score was significantly higher as observed for rest score.
|
|

View larger version (14K):
[in a new window]
|
FIGURE 3. Patients' gated 99mTc-tetrofosmin SPECT segmental stress and rest scores in injected and noninjected segments. (A) Patients' segmental stress score improved in injected and noninjected segments. Improvement in injected segments was more pronounced than improvement in noninjected segments. (B) There was a trend toward improvement in rest score in injected and noninjected segments. Magnitude of improvement in rest score was similar in injected and noninjected segments.
|
|
Copyright © 2006 by the Society of Nuclear Medicine.